American Journal of Medical Genetics Part A · 2014 · 36 citations · 18 references
MedicineGeneticsMolecular GeneticsBone MetabolismHuman GeneticsMedical GeneticsBone DevelopmentBone DisordersBone Metabolism DisordersGenetic DisordersOsteogenesisOsteogenesis ImperfectaAutosomal Dominant InheritanceAutosomal Recessive InheritanceCoding Region VariationCol1a1 MutationsCol1a2 MutationsMutation SpectrumMutation Spectrum AnalysisOsteogenesis Imperfecta Genetics
Osteogenesis imperfecta (OI) is a condition of decreased bone density with heterogeneous etiologies. Most of the cases are inherited in an autosomal dominant fashion and are caused by mutations in the COL1A1 or COL1A2 genes. Since these two genes are very large, there are no data about mutations in Indian patients with OI. We selected 35 Indian patients who were clinically diagnosed with OI and all exons of both the genes were sequenced. Mutations in COL1A1 (14 cases, 6 novel) and COL1A2 (11 cases, 7 novel) were identified in 25 patients. A total of 55 polymorphisms were identified in both the genes with eight novel variants in the coding region, and nine novel variants in the non-coding regions. No mutation was detected in 10 patients. Six of them were from consanguineous families, with one or two similarly affected siblings suggesting possible autosomal recessive inheritance. If we exclude families with consanguinity, mutations were identified in 25 out of 29 families giving 86% mutation detection rate. Mutations in COL1A1 accounted for 56% of the cases and COL1A2 44%, which is similar to the reported rate worldwide.
18
Genetic heterogeneity in osteogenesis imperfecta.
David Sillence, A Senn, D. M. Danks · Journal of Medical Genetics · 1979 · 2.2K citations · Full text
Medicine, Genetics, Bone Metabolism +16
Frank Rauch, Francis H. Glorieux · The Lancet · 2004 · 1.2K citations
Chain conformation in the collagen molecule
Russell Fraser, T.P. MacRae, E. Suzuki · Journal of Molecular Biology · 1979 · 318 citations